Promising New Science for Hair Growth
Hair loss affects millions of people worldwide. This creates a demand for innovative treatments that go beyond traditional options. CALECIM Professional Advanced Hair System is an exciting development in this field, using cutting-edge stem cell technology to address hair thinning.
Revolutionary PTT-6 Technology
CALECIM’s breakthrough lies in its active ingredient, – PTT-6, which harnesses the power of umbilical cord lining stem cells. The technology extracts over 3,000 proteins, growth factors, and exosomes from these cells, creating a concentrated cocktail of regenerative signals without using live stem cells.
This sophisticated approach provides hair follicles with the same molecular messages that promote healthy tissue repair and growth. The cord lining represents a particularly rich source of these beneficial factors, with billions of stem cells available from a single cord.
Key growth factors in PTT-6 include VEGF (which improves blood supply to follicles), IGF-1 (which extends the hair growth phase), and numerous anti-inflammatory compounds that create an optimal environment for hair regrowth.
PTT-6® contains over 3,000 proteins, growth factors, and exosomes that signal cells to regenerate naturally.
Impressive Clinical Results
CALECIM’s research demonstrates encouraging outcomes across multiple measures.
Enhanced Follicle Activity – Laboratory studies show PTT-6 increases hair follicle cell growth by 24%, matching the effectiveness of minoxidil in controlled conditions. This suggests the serum can stimulate dormant follicles back into active growth phases.
Powerful Anti-Inflammatory Effects – Testing revealed a remarkable 30-fold reduction in inflammatory markers around hair follicles. Since chronic inflammation contributes significantly to hair loss progression, this anti-inflammatory action helps create conditions favourable for regrowth.
Measurable Hair Improvements – A clinical study tracking 10 patients over 12 weeks documented impressive results: a 14% increase in hair count, a 16% increase in hair thickness, and a 15% increase in follicle density. These improvements were measured using sophisticated imaging technology, providing objective evidence of the treatment’s effectiveness.
Rapid Results – Users of the product report visible improvements within 6 weeks, some noticing reduced hair shedding and new growth appearing relatively quickly compared to other treatments.
Whilst this initial study involved a small group, the consistently positive outcomes across all participants suggest genuine therapeutic potential. Larger studies are currently planned to further validate these promising findings.
Targeting the Root Cause
CALECIM’s approach focuses on addressing inflammation, which research increasingly recognises as a significant factor in hair loss. Studies show inflammatory cells accumulate around shrinking hair follicles in pattern baldness, potentially accelerating the miniaturisation process.
By providing concentrated anti-inflammatory signals directly to the scalp, PTT-6 helps counteract this damaging inflammatory environment. The 30-fold reduction in inflammatory markers demonstrates the product’s potency in this area.
This mechanism offers particular promise for individuals whose hair loss involves inflammatory components, potentially helping follicles recover from damage and resume normal growth cycles.
Excellent Safety Profile
One of CALECIM’s most attractive features is its outstanding safety record. Clinical studies have reported no adverse effects, and real-world use by thousands of people worldwide has not yielded any significant side effect reports.
This safety profile stems from the product’s biological nature – being derived from natural cell secretions rather than synthetic chemicals. The hormone-free formulation means it avoids the potential side effects associated with treatments like finasteride.
Dr Neil Sadick, a renowned dermatologist involved in PTT-6 research, notes the product is even safe for use during pregnancy due to its 100% hormone-free composition.
Growing Medical Recognition
CALECIM is gaining acceptance within the aesthetic medicine community. Research has been published in peer-reviewed journals, with respected practitioners like Dr Neil Sadick and Dr Munir Somji endorsing the technology based on their clinical experience.
The product has also received industry recognition, winning “Best Topical for Hair Growth” at the 2023 Get the Gloss Wellness Awards. This award highlighted its innovative approach to hair restoration.
Leading hair restoration specialist Kelly Morrell reports excellent results with CALECIM, noting success even in patients who were previously unresponsive to minoxidil. Her clinical observations support the research findings about the product’s effectiveness.
GROWTH FACTORS
PROTEINS
EXOSOMES
Scientific Foundation
The science behind CALECIM builds on decades of stem cell research. Parent company CellResearch Corporation discovered cord lining stem cells in 2004 and has extensively studied their regenerative properties.
The company’s commitment to research extends beyond cosmetics – they currently have FDA-cleared trials using cord lining stem cells for treating diabetic foot ulcers, demonstrating the serious medical potential of this technology.
This strong research foundation distinguishes CALECIM from many hair loss products that lack scientific backing.
Treatment Approach and Expectations
CALECIM works differently from traditional hair loss treatments. Rather than blocking hormones or artificially stimulating growth, it provides the natural signals that support healthy hair follicle function.
The treatment protocol typically involves a 6-week intensive course followed by maintenance applications. Clinical data suggests optimal results develop over 3 months, though some benefits may be visible earlier.
The improvements documented in studies represent meaningful changes that can make a noticeable difference in hair appearance and confidence. Whilst individual results may vary, the consistently positive outcomes in clinical testing suggest good potential for success.
Innovative Alternative
For those seeking alternatives to pharmaceutical treatments or looking to supplement existing therapies, CALECIM offers an innovative option backed by genuine scientific research.
The product’s cosmetic regulatory status allows easy access without prescription requirements, whilst the stem cell technology provides a sophisticated approach to hair restoration.
As research continues and larger studies are completed, CALECIM may well establish itself as a significant advancement in non-pharmaceutical hair loss treatment.
The combination of cutting-edge science, impressive initial results, and an excellent safety profile makes CALECIM Professional an exciting development for anyone concerned about hair thinning. With respected medical professionals endorsing its use and clinical data supporting its effectiveness, this represents a promising new chapter in hair restoration science.
More information on CALECIM Professional Advanced Hair System can be found on the CALECIM website.
To book a consultation today at 01603 360360 or message us please use our contact page
